Several neurodegenerative disorders are characterized by intracellular protein accumulations or inclusions, such as the Lewy bodies of Parkinson's disease. Although little is know about the origin of these accumulations and their specific affect on neurons, it seems likely that as they grow they prove fatal to the cell. Here Michael Brownstein and colleagues speculate on a broad role for alpha synuclein in the development of Lewy bodies and the other protein inclusions associated with neurodegeneration.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Genealogy of the neurodegenerative diseases based on a meta-analysis of age-stratified incidence data
Scientific Reports Open Access 03 November 2020
-
Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
Molecular Neurodegeneration Open Access 19 November 2019
-
An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity
Cell Death & Disease Open Access 30 August 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Polymeropoulos, M.H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–7 (1997).
Kruger, R. et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Cenet. 18, 1(1998).
Spillantini, M.C. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839–40 (1998).
Lowe, J. et al. Ubiquitin carboxyl-terminal hydrolase (PGP9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative disorders. J. Pathol. 161, 153–601 (1990).
li, K., Ito, H., Tanaka, K. & Hirano, A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56, 125–131 (1997).
Hochstrasser, M. Ubiquitin-dependent protein degradation. Annu. Rev. Cenet. 30, 405–39 (1996).
Hilt, W. & Wolf, D.H. Proteasomes: destruction as a programme. Trends Biochem. Sci. 21, 96–102 (1996).
Coux, O., Tanaka, K. & Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801–47 (1996).
Jenco, J.M., Rawlingson, A., Daniels, B. & Morris, A.J. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Biochem. 37, 4901–9 (1998).
Maroteaux, L. & Scheller, R.H. The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Mol. Brain Res. 11, 335–343 (1991).
Graham, J.G. & Oppenheimer, D.R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 32, 28–34 (1969).
Quinn, N. & Wenning, G. Multiple system atrophy. Current Opinion Neurol. 8, 323–326 (1995).
Papp, M.I., Kahn, J.E. & Lantos, P.L. Glial cytoplasrnic inclusions in the CMS of patients with multiple system atrophy (striatonigral degeneration, olivoponto-cerebellar atrophy, and Shy-Drager syndrome). J. Neurol. Sci. 94, 79–100 (1989).
Nakazato, Y. et al. Oligodendroglial microtubular tangles in olivopontocere-bellar atrophy. J. Neuropathol. Exp. Neurol. 49, 521–530 (1990).
Rosen, D.R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59–62 (1993).
Mezey, E. et al. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol. Psychiatry (in press).
DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–3 (1997).
Paulson, H.L. et al. Ubiquitinated nuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD). Neurol. 50, Suppl. 2, A310–A311 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mezey, E., Dehejia, A., Harta, G. et al. Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?. Nat Med 4, 755–757 (1998). https://doi.org/10.1038/nm0798-755
Issue Date:
DOI: https://doi.org/10.1038/nm0798-755
This article is cited by
-
Genealogy of the neurodegenerative diseases based on a meta-analysis of age-stratified incidence data
Scientific Reports (2020)
-
Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
Molecular Neurodegeneration (2019)
-
Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein
Molecular Psychiatry (2017)
-
An integrated targeted metabolomic platform for high-throughput metabolite profiling and automated data processing
Metabolomics (2015)
-
Targeting the Chameleon: a Focused Look at α-Synuclein and Its Roles in Neurodegeneration
Molecular Neurobiology (2013)